[Differentiation of benign and malignant palpable breast masses using 99mTc-MIBI imaging].
Forty-two patients with palpable breast masses were examined by 99mTc-MIBI imaging. All the results were compared with ultra-red scanning and B-ultrasongraphy. By pathological examination 26 out of 42 cases had breast carcinoma, 16 patients benign lesions. The sensitivity of 99mTc-MIBI imaging was 92.3%, the specificity was 96.0% and the accuracy 92.8%, which were higher than those of ultra-red scanning and B-ultrasound (P < 0.01). The authors consider that 99mTc-MIBI breast imaging is useful in distinguishing malignancies from benign breast masses.
He
J
J
Department of Nuclear Medicine, Second Affiliated Hospital, Hunan Medical University, Changsha.
Li
Y
Y
Su
J
J
D000236:Adenoma / Q000000981:diagnostic imaging*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D018270:Carcinoma, Ductal, Breast / Q000000981:diagnostic imaging*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D014463:Ultrasonography
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi